Ticker Details
Larimar Therapeutics, Inc. Common Stock
IPO Date:	July 1, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$358.4M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 3.87%
Avg Daily Range (30 D):	$0.12 | 2.94%
Avg Daily Range (90 D):	$0.16 | 3.86%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	1.51M
Avg Daily Volume (90 D):	3.27M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	119
Avg Trade Size (Sh.) (90 D):	157

Institutional Trades
Total Institutional Trades:	270
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$.92M
Avg Institutional Trade (90 D):	$.99M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.37M
Avg Closing Trade (30 D):	$.61M
Avg Closing Trade (90 D):	$.83M
Avg Closing Volume:	242.6K

News

Feb 26, 2026 @ 1:59 AM Larimar Therapeutics Announces Pricing of Upsized ... Source: Globe Newswire

Feb 26, 2026 @ 1:59 AM Larimar Therapeutics Announces Pricing of Upsized ... Source: Na

Oct 16, 2025 @ 8:44 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Prnewswire

Oct 16, 2025 @ 1:30 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Business Wire

Oct 16, 2025 @ 1:09 AM LRMR Investors Have Opportunity to Join Larimar Th... Source: Business Wire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS
Diluted EPS
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-29.61M	$-62.5M	$-165.67M
Operating Income / Loss	$-31.12M	$-64.02M	$-172.5M
Cost of Revenue
Net Cash Flow	$92.5M		$52.19M
PE Ratio